Effect of amalaki swarasa bhavita haridra churna in patients with diabetic dyslipidemia.

Effect of amalaki (Emblica officinalis Gaertn.) swarasa bhavita haridra (Curcuma longa Linn.) churna in patients with diabetic dyslipidemia. - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054879

Enrollment

Registered

2023-07-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E889- Metabolic disorder, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Type 2 diabetes mellitus with : a) FBS more than 110mg/dl and less than 200 mg/dl. b) PPBS greater than 140 mg/dl and less than 240 mg/dl. c) HbA1C in range of 6.5 to 8. 2) LDL in the range 130 mg/dl and above. 3) Individuals ready to follow all procedures.

Exclusion criteria

Exclusion criteria: 1) Individuals with known history of cardiac pathology, Chronic kidney disease, liver pathologies and hematological disorders. 2) Individuals with known history of any other endocrinological disease like hypothyroidism, aldosteronism etc. 3) Pregnant and lactating females. 4) Participants who are already administering medication for dyslipidemia and diabetes.

Design outcomes

Primary

Measure	Time frame
Assessment of diabetic dyslipidemia by reduction in LDL, FBS, PPBS and HbA1C.Timepoint: Assessment of LDL, FBS, & PPBS on before treatment, after 1st month, after 2nd month and after 3rd month. Assessment of HbA1C on before treatment and after treatment. Total course of intervention - 3months.	—

Secondary

Measure	Time frame
Antidiabetic & anti hyperlipidemic effect of amalaki swarasa bhavita haridra churna.Timepoint: Assessment of LDL, FBS, & PPBS on before treatment, after 1st month, after 2nd month & after 3rd month. Assessment of HbA1C on before treatment & after treatment. Total course of intervention- 3 months	—

Countries

India

Contacts

Public ContactDr Shincymol VV

Government Ayurveda College and Hospital, Tripunithura

vvshincymol@gmail.com9947012863

Outcome results